Dr. Pennesi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3375 Sw Terwilliger Blvd
CEI
Portland, OR 97239Phone+1 503-494-8386- Is this information wrong?
Education & Training
- University of PennsylvaniaBS, Bioengineering, Summa Cum Laude, 1997
- Oregon Health Science University HospitalFellowship, Ophthalmic Genetics and Inherited Retinal Degeneration, 2008 - 2009
- University of California2005 - 2008
- Scripps Mercy Hospital2005 - 2005
- Baylor College of MedicineClass of 2004
- Baylor College of MedicinePh.D, Neuroscience, 2003 - 2003
Certifications & Licensure
- CA State Medical License 2006 - Present
- OR State Medical License 2008 - 2025
- TX State Medical License 2023 - 2024
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Scientist Research Award ARVO/Alcon Early Clinician, 2011
- Travel Award International Society for Clinical Electrophysiology in Vision, 2009
- Join now to see all
Clinical Trials
- Rate of Progression in USH2A-related Retinal Degeneration Start of enrollment: 2017 Aug 11
Publications & Presentations
PubMed
- Comparative analysis of in-silico tools in identifying pathogenic variants in dominant inherited retinal diseases.Daniel C Brock, Meng Wang, Hafiz Muhammad Jafar Hussain, David E Rauch, Molly Marra, Mark E Pennesi, Paul Yang, Lesley Everett, Radwan S Ajlan, Jason Colbert, Fernanda...> ;Human Molecular Genetics. 2024 Mar 7
- Assessment of Visual Function With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa in the Randomized XIRIUS Phase 2/3 Study.Panda, S., Gow, J., Zhao, G., MacLaren, R., , Lam, B., Pennesi, M., Kay, C.> ;Ophthalmology. 2024 Feb 27
- A Prospective, Observational, Noninterventional Clinical Study of Participants With Choroideremia: The NIGHT Study.Robert E Maclaren, Byron L Lam, M Dominik Fischer, Frank G Holz, Mark E Pennesi, David G Birch, Eeva-Marja Sankila, Isabelle Anne Meunier, Kimberly E Stepien, Juliana ...> ;American Journal of Ophthalmology. 2024 Feb 3
- Join now to see all
Journal Articles
- Strategies for Treating Inherited Retinal Degeneration with Large Genes That Are Not Amenable to Adeno-Associated Virus–Based Gene Replacement TherapyMark E Pennesi, Richard G Weleber, JAMA Ophthalmology
- Disease Course in Patients with Pentosan Polysulfate Sodium–Associated Maculopathy After Drug CessationJoseph M Simonett, Mark E Pennesi, Nieraj Jain, JAMA Ophthalmology
- Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients with Autosomal Dominant Retinitis PigmentosaDavid G Birch, Michael P Teske, Richard G Weleber, Robert Lindblad, Byron L Lam, Judith Warner, Gary Edd Fish, Neal L Sklaver, Mark E Pennesi, John Heckenlively, Paul ..., JAMA
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Lentiviral Vector for Gene Replacement Therapy in Stargardt Disease and Usher Syndrome Type IB.Wilson D, Stout JT, Weleber RG, Pennesi ME, Francis PJ, Sahel J, Mohand-Said S, Naylor S Audo I, Macula Society, Jerusalem Israel
- Imaging the Cone Mosaic using a Commerically available Adaptive Optics Flood Illuminated Camera and Examining its Potential as an Endpoint for Clinical Trials.Pennesi ME, Fay JD, Faridi A, Garg AK, Chegarnov EN, Michaels KV, International Society for Clinical Electrophysiology in Vision, Valencia, Spain
- Hand-Held Spectral-Domain Optical Coherence Tomography in the Evaluation of Patients in a Pediatric Ophthalmic Genetics Clinic.Pennesi ME, Courtney RJ, Francis PJ, Weleber RG, International Society for Clinical Electrophysiology in Vision, Quebec City, Montreal
- Join now to see all
Lectures
- SD-OCT of Mice and Men.Coordes Conference, UCSF
- Retinitis Pigmentosa.Foundation Fighting Blindness, Visions Conference
- The Advantages of Hand-held sdOCT for Studying Retinal Degeneration in Infants and Animal Models.National Eye Institute
- Join now to see all
Authored Content
- Disease Course in Patients with Pentosan Polysulfate Sodium–Associated Maculopathy After Drug CessationJuly 2020
- Disease Course in Patients with Pentosan Polysulfate Sodium–Associated Maculopathy After Drug CessationJuly 2020
- Disease Course in Patients with Pentosan Polysulfate Sodium–Associated Maculopathy After Drug CessationJuly 2020
Press Mentions
- Endogena Therapeutics Completes Dose Escalation in the Phase 1/2a Clinical Trial of EA-2353 for the Treatment of Retinitis PigmentosaApril 5th, 2023
- Where Should Society Draw Ethical Lines for Experimental CRISPR Gene Therapies That Appear Able to Cure Diseases?April 13th, 2022
- US FDA Accepts Ocugen Inc.’s (NASDAQ: OCGN) Investigational New Drug Application TO Commence Phase 1/2 OCU400 StudyDecember 23rd, 2021
- Join now to see all
Grant Support
- Serotonin Receptor Modulation Of Neurotrophic Factors In The RetinaNational Eye Institute2011–2012
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: